Ketamine Gets Controversial FDA Approval for Depression Treatment SciShow News

The video discusses treatment resistant depression and the FDA's approval of a new antidepressant, esketamine, which acts quickly and may help long-term. Despite promising results, concerns about its efficacy and cost remain. Additionally, recent studies suggest ultrasound could treat inflammatory and metabolic disorders by stimulating nerves, offering a non-invasive alternative to current methods. Both treatments highlight the potential for innovative approaches in addressing complex medical issues.

What new insight or understanding did you gain from this video?